 Heubach Colorants India Ltd Q2 FY2026 PAT at Rs. 16.28 crores
Heubach Colorants India Ltd Q2 FY2026 PAT at Rs. 16.28 crores Indiabulls Ltd Q2 FY2025-26 consolidated profit at Rs. 0.71 crore
Indiabulls Ltd Q2 FY2025-26 consolidated profit at Rs. 0.71 crore LKP Securities Ltd consolidated Q2FY26 PAT lower at Rs. 2.66 crore
LKP Securities Ltd consolidated Q2FY26 PAT lower at Rs. 2.66 crore NTPC Green Energy Ltd Signs MoU with CtrlS Datacenter Limited for development of RE Projects
NTPC Green Energy Ltd Signs MoU with CtrlS Datacenter Limited for development of RE Projects Lemon Tree Hotels signs 11th property in Punjab
Lemon Tree Hotels signs 11th property in Punjab 
              The Board of Directors of Lincoln Pharmaceuticals Ltd at their meeting held on October 27, 2016 have considered and approved, issue and allotment of 36,89,200 Equity Shares to the Warrant holders belonging to Promoter/Promoter Group and Non-Promoter Group on account of exercise of their right of Conversion of Warrants into Equity Shares at an exercise price of Rs. 82/- Per Share.
The Board Meeting commenced at 10:30 A.M. and concluded at 11:15 A.M.
Shares of LINCOLN PHARMACEUTICALS LTD. was last trading in BSE at Rs.232.95 as compared to the previous close of Rs. 233.8. The total number of shares traded during the day was 25436 in over 663 trades.
The stock hit an intraday high of Rs. 240.3 and intraday low of 231.55. The net turnover during the day was Rs. 5979389.